The goal of this 2.5-years Postdoc training is the introduction into current and timely research themes and innovative technologies at the intersection of basic and clinical research. The Medical Scientists in UMESciA (https://www.uni-due.de/med/umescia/) will closely interact with the Clinical Scientists of the UMEA program (Universitätsmedizin Essen Clinician Scientist Academy; https://www.uni-due.de/med/umea/index.php) to foster direct access to clinical biosamples and deep understanding of clinically relevant research topics. The scientific activities are accompanied by a structured qualification program and awarded with a certificate at the end of the 2.5 year program. Parallel academic qualification towards habilitation is supported by UMESciA.
Research in UMESciA is embedded within the research interfaces of immuno-oncology and immunotherapy with intensive collaborations into the other research focus areas of the faculty: cardiovascular medicine, transplantation, and translational neuro and behavioral sciences.
The primary research scheme of UMESciA will address immunobiological mechanisms and therapies of cancer, immunotherapy-driven cardio-vascular side effects, innovative adoptive cellular therapy, and the interplay of infection and cancer.
These positions are ideal for candidates, who have already published in high-ranking journals and now wish to continue their career in one of the leading cancer centers in Germany. You will be embedded into a vibrant network of translational researchers with active interconnection to the local German Cancer Consortium and Clinician Scientist Programs.
In UMESciA, you can apply for one of seven research projects. Detailed information on these projects is found on our website: www.uni-due.de/med/umescia/projects_2026.php
Details on the application process together with a list of required documents can be found here : https://www.uni-due.de/med/umescia/application.php
